Fore Biotherapeutics, a biotech company developing novel cancer therapies, announced today that it has appointed Bill Hinshaw as its new Chief Executive Officer and Board member, effective immediately. Mr. Hinshaw succeeds Dr. Shawn M. Leland, who served as Advisor and Interim CEO during the transition period and will continue to support the company as a…